Abstract
CKD is a unique character on the stage of noncommunicable diseases in the United States: high prevalence (>20% in adults), significant expense to public payers ($114 billion among Medicare fee-for-service enrollees), and relatively little investment in research ($29 per patient in National
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have